Multilocus sequence typing reveals genetic diversity of carbapenem- or ceftazidime-nonsusceptible Pseudomonas aeruginosa in China

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 11, 2013, Pages 5697-5700

  Ji, Jingshu ^a   Wang, Jie ^b   Zhou, Zhihui ^a   Wang, Haiping ^a   Jiang, Yan ^a   Yu, Yunsong ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CEFTAZIDIME; IMIPENEM; MEROPENEM;

ALLELE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHINA; GENETIC VARIABILITY; MOLECULAR CLONING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; CEFTAZIDIME; CHINA; GENETIC VARIATION; HUMANS; MULTILOCUS SEQUENCE TYPING; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84885909057     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00970-13     Document Type: Article

References (23)

1. Pagani L, Colinon C, Migliavacca R, Labonia M, Docquier JD, Nucleo E, Spalla M, Li Bergoli M, Rossolini GM. 2005. Nosocomial outbreak caused by multidrug-resistant Pseudomonas aeruginosa producing IMP-13 metallo-beta- lactamase. J. Clin. Microbiol. 43:3824-3828.
2. Gibson RL, Burns JL, Ramsey BW. 2003. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care Med. 168:918-951.
3. Khan NH, Ishii Y, Kimata-Kino N, Esaki H, Nishino T, Nishimura M, Kogure K. 2007. Isolation of Pseudomonas aeruginosa from open ocean and comparison with freshwater, clinical, and animal isolates. Microb. Ecol. 53:173-186.
4. Pirnay JP, Matthijs S, Colak H, Chablain P, Bilocq F, Van Eldere J, De Vos D, Zizi M, Triest L, Cornelis P. 2005. Global Pseudomonas aeruginosa biodiversity as reflected in a Belgian river. Environ. Microbiol. 7:969-980.
5. Jean SS, Hsueh PR. 2011. High burden of antimicrobial resistance in Asia. Int. J. Antimicrob. Agents 37:291-295.
6. Lyczak JB, Cannon CL, Pier GB. 2002. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15:194-222.
7. Wang H, Chen M, China Nosocomial Pathogens Resistance Surveillance Study Group. 2005. Surveillance for antimicrobial resistance among clinical isolates of gram-negative bacteria from intensive care unit patients in China, 1996 to 2002. Diagn. Microbiol. Infect. Dis. 51:201-208.
8. Woodford N, Turton JF, Livermore DM. 2011. Multiresistant Gramnegative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev. 35:736-755.
9. Goto H, Shimada K, Ikemoto H, Oguri T, Study Group on Antimicrobial Susceptibility of Pathogens Isolated from Respiratory Infections. 2009. Antimicrobial susceptibility of pathogens isolated from more than 10,000 patients with infectious respiratory diseases: a 25-year longitudinal study. J. Infect. Chemother. 15:347-360.
10. Morrow BJ, Pillar CM, Deane J, Sahm DF, Lynch AS, Flamm RK, Peterson J, Davies TA. 2013. Activities of carbapenem and comparator agents against contemporary US Pseudomonas aeruginosa isolates from the CAPITAL surveillance program. Diagn. Microbiol. Infect. Dis. 75: 412-416.
11. Empel J, Filczak K, Mrowka A, Hryniewicz W, Livermore DM, Gniadkowski M. 2007. Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum beta-lactamase in Warsaw, Poland: further evidence for an international clonal complex. J. Clin. Microbiol. 45:2829-2834.
12. Jacobson RK, Minenza N, Nicol M, Bamford C. 2012. VIM-2 metallobeta-lactamase-producing Pseudomonas aeruginosa causing an outbreak in South Africa. J. Antimicrob. Chemother. 67:1797-1798.
13. Elias J, Schoen C, Heinze G, Valenza G, Gerharz E, Gerharz H, Vogel U. 2010. Nosocomial outbreak of VIM-2 metallo-beta-lactamaseproducing Pseudomonas aeruginosa associated with retrograde urography. Clin. Microbiol. Infect. 16:1494-1500.
14. Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG. 2004. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J. Clin. Microbiol. 42:5644-5649.
15. Wiehlmann L, Wagner G, Cramer N, Siebert B, Gudowius P, Morales G, Kohler T, van Delden C, Weinel C, Slickers P, Tummler B. 2007. Population structure of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 104:8101-8106.
16. Maatallah M, Cheriaa J, Backhrouf A, Iversen A, Grundmann H, Do T, Lanotte P, Mastouri M, Elghmati MS, Rojo F, Mejdi S, Giske CG. 2011. Population structure of Pseudomonas aeruginosa from five Mediterranean countries: evidence for frequent recombination and epidemic occurrence of CC235. PLoS One 6:e25617. doi:10.1371/journal.pone.0025617.
17. Pirnay JP, Bilocq F, Pot B, Cornelis P, Zizi M, Van Eldere J, Deschaght P, Vaneechoutte M, Jennes S, Pitt T, De Vos D. 2009. Pseudomonas aeruginosa population structure revisited. PLoS One 4:e7740. doi:10.1371/journal.pone. 0007740.
18. Kidd TJ, Ritchie SR, Ramsay KA, Grimwood K, Bell SC, Rainey PB. 2012. Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting. PLoS One 7:e44199. doi:10.1371/journal.pone.0044199.
19. CLSI. 2012. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. CLSI document M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA.
20. Viedma E, Juan C, Villa J, Barrado L, Orellana MA, Sanz F, Otero JR, Oliver A, Chaves F. 2012. VIM-2-producing multidrug-resistant Pseudomonas aeruginosa ST175 clone, Spain. Emerg. Infect. Dis. 18:1235-1241.
21. Yoo JS, Yang JW, Kim HM, Byeon J, Kim HS, Yoo JI, Chung GT, Lee YS. 2012. Dissemination of genetically related IMP-6-producing multidrug-resistant Pseudomonas aeruginosa ST235 in South Korea. Int. J. Antimicrob. Agents 39:300-304.
22. Hrabák J, Cervena D, Izdebski R, Duljasz W, Gniadkowski M, Fridrichova M, Urbaskova P, Zemlickova H. 2011. Regional spread of Pseudomonas aeruginosa ST357 producing IMP-7 metallo-beta-lactamase in Central Europe. J. Clin. Microbiol. 49:474-475.
23. Fu Y, Zhou J, Zhou H, Yang Q, Wei Z, Yu Y, Li L. 2010. Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China. J. Antimicrob. Chemother. 65:644-650.